Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
Tags Bristol/Myers Squibb Co Health care industry Pfizer Inc
From CNBC.com News
5 European stocks to watch this earnings season as Trump's tariffs hit
Tickers OIL
Tags Markets Energy Stellantis NV
From CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
Tags Companies Pharmaceuticals Health care industry
From CNBC.com News
CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine
Tags UBS Group AG Pfizer Inc Markets
From CNBC.com News
Pfizer scraps daily weight loss pill after liver injury in one patient
Tags Breaking News: Business Biotech and Pharmaceuticals US: News
From CNBC.com News
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback
Tags Breaking News: Politics Business Europe News
From CNBC.com News
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
Tags Social issues Health & Science Business
From CNBC.com News
The biggest winners and losers in Europe as Trump announces sweeping tariffs
Tags AstraZeneca PLC GSK plc Europe News
From CNBC.com News
Pharma tariff relief likely short-lived with sector-specific duties on the horizon
Tags Novo Nordisk A/S Trade Biotechnology
From CNBC.com News
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
Tags Health & Science Business Novo Nordisk A/S
From CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
Tags Pharmaceuticals Novo Nordisk A/S Biotechnology
From CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Tags LILLY DRN Biotechnology Pharmaceuticals
From CNBC.com News
CNBC Daily Open: Consumers and CFOs alike are expecting a recession in the U.S.
Tags Daily Open BYD Co Ltd Microstrategy Inc
From CNBC.com News
CNBC Daily Open: Fears of a U.S. recession intensify among consumers and CFOs
Tags Market Outlook World Markets SAP AG
From CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
Tags LILLY DRN Novo Nordisk A/S Science
From CNBC.com News
Software giant SAP becomes Europe's most valuable firm amid German stock market boom
Tags Europe Markets Breaking News: Markets LVMH Moet Hennessy Louis Vuitton SE
From CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Tags Viking Therapeutics Inc Breaking News: Business US: News
From CNBC.com News
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
Tags Pharmaceuticals Business LILLY DRN
From CNBC.com News
Zepbound copycats remain online despite FDA ban
Tags Health care industry Pharmaceuticals Retail industry
From CNBC.com News
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests
Tags Health care industry Social issues Health & Science
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Business News Technology Investing
From CNBC.com News
Novo Nordisk shares fall 5.5% after latest trial results for its next-generation weight loss drug
Tags Europe Markets Biotech and Pharmaceuticals Breaking News: Europe
From CNBC.com News
Amgen starts two critical late-stage trials for weight loss drug MariTide
Tags Business News Biotechnology LILLY DRN
From CNBC.com News
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
Tags Health & Science Business Health care industry
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Abbvie Inc Zealand Pharma A/S Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
Tags Business Health & Science Pharmaceuticals
From CNBC.com News
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
Tags Health care industry Pharmaceuticals Companies
From CNBC.com News
Cramer's Lightning Round: Sunoco is a buy
Tags Markets U/S/ Markets Anheuser/Busch Inbev SA
From CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
Tags Health care industry Social issues Health & Science
From CNBC.com News
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
Tags Novo Nordisk A/S US Economy Europe Economy
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.